Inovio Pharmaceuticals Stock Price on September 3, 2024
| INO Stock | USD 4.07 0.01 0.25% |
Below is the normalized historical share price chart for Inovio Pharmaceuticals extending back to December 08, 1998. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Inovio Pharmaceuticals stands at 4.07, as last reported on the 24th of November, with the highest price reaching 4.22 and the lowest price hitting 4.04 during the day.
If you're considering investing in Inovio Stock, it is important to understand the factors that can impact its price. Inovio Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.26, which attests that the entity had a -0.26% return per unit of risk over the last 3 months. Inovio Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inovio Pharmaceuticals' Risk Adjusted Performance of (0.19), market risk adjusted performance of (0.41), and Standard Deviation of 3.34 to validate the risk estimate we provide.
At this time, Inovio Pharmaceuticals' Common Stock Shares Outstanding is very stable compared to the past year. As of the 24th of November 2024, Other Stockholder Equity is likely to grow to about 1.8 B, while Total Stockholder Equity is likely to drop about 95.2 M. . As of the 24th of November 2024, Price To Sales Ratio is likely to drop to 154.95. In addition to that, Price Earnings Ratio is likely to drop to -1.05. Inovio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of February 1998 | 200 Day MA 8.6394 | 50 Day MA 5.499 | Beta 0.833 |
Inovio |
Sharpe Ratio = -0.262
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INO |
Estimated Market Risk
| 3.36 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.88 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.26 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Inovio Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inovio Pharmaceuticals by adding Inovio Pharmaceuticals to a well-diversified portfolio.
Price Book 1.4409 | Enterprise Value Ebitda (1.09) | Price Sales 179.4806 | Shares Float 23.5 M | Wall Street Target Price 10.6667 |
Related Headline
Elevation Oncology Headline on 3rd of September 2024
Affimed Appoints Shawn M. Leland as Chief Executive Officer by finance.yahoo.com
MANNHEIM, Germany, Sept. 03, 2024 -- Affimed N.V. , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that Shawn M. Leland, PharmD, RPh has been appointed as Chief Executive Officer . Dr. Andreas Harstrick, who has been serving as acting CEO since January 2024 will continue in his position as Chief Medical Officer . Shawn is an accomplished pharmace
Inovio Pharmaceuticals Valuation on September 3, 2024
It is possible to determine the worth of Inovio Pharmaceuticals on a given historical date. On September 3, 2024 Inovio was worth 7.2 at the beginning of the trading date compared to the closed value of 6.43. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Inovio Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Inovio Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inovio Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Inovio Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 7.41 | 7.55 | 7.13 | 7.22 | 207,354 | |
09/03/2024 | 7.20 | 7.22 | 6.41 | 6.43 | 399,577 |
| 6.33 | 6.74 | 6.33 | 6.58 | 255,937 |
| Backtest Inovio Pharmaceuticals | | | Inovio Pharmaceuticals History | | | Inovio Pharmaceuticals Valuation | Previous | Next |
Inovio Pharmaceuticals Trading Date Momentum on September 3, 2024
| On September 04 2024 Inovio Pharmaceuticals was traded for 6.58 at the closing time. Highest Inovio Pharmaceuticals's price during the trading hours was 6.74 and the lowest price during the day was 6.33 . The net volume was 255.9 K. The overall trading history on the 4th of September contributed to the next trading period price boost. The trading delta at closing time to the next next day price was 2.33% . The trading delta at closing time to current price is 4.04% . |
Inovio Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Inovio Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Inovio Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Inovio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Inovio Pharmaceuticals Stock history
Inovio Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inovio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inovio Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inovio Pharmaceuticals stock prices may prove useful in developing a viable investing in Inovio Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 22.2 M | 28 M | |
| Net Loss | -251.8 M | -239.2 M |
Inovio Pharmaceuticals Quarterly Net Working Capital |
|
Inovio Pharmaceuticals Stock Technical Analysis
Inovio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Inovio Pharmaceuticals Period Price Range
Low | November 24, 2024
| High |
0.00 | 0.00 |
Inovio Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Inovio Pharmaceuticals November 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Inovio Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inovio Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Inovio Pharmaceuticals stock market strength indicators, traders can identify Inovio Pharmaceuticals entry and exit signals to maximize returns
Inovio Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Inovio Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Inovio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inovio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (1.10) | |||
| Total Risk Alpha | (1.38) | |||
| Treynor Ratio | (0.42) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Revenue Per Share 0.025 | Quarterly Revenue Growth (0.55) | Return On Assets (0.40) | Return On Equity (0.91) |
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.